David Tapolczay

Insider Reports History

Entity
Individual
Location
32 Crouch Hall Lane, St. Albans, United Kingdom
Signature
/s/ David Tapolczay
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Tapolczay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CONDUIT PHARMACEUTICALS INC. Chief Executive Officer, Director Stock Option (Right to Buy) 840K $77.2K $0.09 Nov 18, 2024 Direct
CONDUIT PHARMACEUTICALS INC. Chief Executive Officer, Director Warrant (Right to buy) 200K Apr 22, 2024 Direct

Insider Reports Filed by David Tapolczay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDT CONDUIT PHARMACEUTICALS INC. Nov 18, 2024 1 $77.2K 4 Nov 20, 2024 Chief Executive Officer, Director
CDT CONDUIT PHARMACEUTICALS INC. Apr 22, 2024 2 $0 4 Apr 24, 2024 Chief Executive Officer, Director
CDT CONDUIT PHARMACEUTICALS INC. Dec 1, 2023 1 $1.64M 4 Dec 5, 2023 Director
MURF CONDUIT PHARMACEUTICALS INC. Sep 22, 2023 0 $0 3 Sep 26, 2023 Chief Executive Officer, Director